Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Rigaku Holdings ¥129.1 billion IPO
The shares are listed on the Tokyo Stock Exchange
Pony AI $413 million IPO
We advised Pony AI on its IPO, concurrent private placements and Nasdaq listing
Tokyo Metro privatization and ¥348.6 billion IPO
The deal is the largest Japanese IPO since 2018
Horizon Robotics HK$5.41 billion IPO
We advised Horizon Robotics on its IPO and HKEX listing
Bold Eagle Acquisition $250 million IPO
The units are listed on the Nasdaq Global Market
MBX Biosciences $188 million IPO
The shares are listed on the Nasdaq Global Select Market
XCHG IPO
We advised XCHG on its IPO and Nasdaq listing